| Literature DB >> 29945552 |
Shengru Wu1, Yanli Liu1, Wei Guo1, Xi Cheng1, Xiaochun Ren2, Si Chen1, Xueyuan Li1, Yongle Duan1, Qingzhu Sun1, Xiaojun Yang3.
Abstract
BACKGROUND: The liver is mainly hematopoietic in the embryo, and converts into a major metabolic organ in the adult. Therefore, it is intensively remodeled after birth to adapt and perform adult functions. Long non-coding RNAs (lncRNAs) are involved in organ development and cell differentiation, likely they have potential roles in regulating postnatal liver development. Herein, in order to understand the roles of lncRNAs in postnatal liver maturation, we analyzed the lncRNAs and mRNAs expression profiles in immature and mature livers from one-day-old and adult (40 weeks of age) breeder roosters by Ribo-Zero RNA-Sequencing.Entities:
Keywords: Chicken; Differential expression; LncRNAs; Postnatal liver maturation; Transcriptome
Mesh:
Substances:
Year: 2018 PMID: 29945552 PMCID: PMC6020324 DOI: 10.1186/s12864-018-4891-7
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Statistical data of the RNA-Sequencing reads for six samples
| Mature liver | Immature liver | |||||
|---|---|---|---|---|---|---|
| M1 | M2 | M3 | IM1 | IM2 | IM3 | |
| Q20 (%) | 99.53 | 99.55 | 99.51 | 99.56 | 99.47 | 99.52 |
| Q30 (%) | 95.48 | 95.49 | 94.78 | 95.66 | 94.67 | 94.89 |
| GC content (%) | 51 | 52.5 | 50 | 50 | 51 | 50 |
| Raw reads | 85,224,338 | 90,000,000 | 76,894,960 | 90,000,000 | 89,618,576 | 90,000,000 |
| Valid reads | 73,446,942 | 78,312,446 | 66,231,654 | 64,371,012 | 56,267,806 | 66,562,834 |
| Mapped reads | 67,733,671 | 69,790,614 | 58,100,222 | 55,492,843 | 44,247,356 | 53,016,014 |
| Unique genes | 20,158 | 19,726 | 19,751 | 19,351 | 19,543 | 19,687 |
| Unique lncRNAs | 1918 | 1927 | 1932 | 2019 | 2042 | 2022 |
Fig. 1Characteristics of lncRNAs in the livers of chickens (Gallus gallus). a. the expression level of lncRNAs (log10FPKM) along the Gallus gallus chromosomes. It comprises six concentric rings, and each corresponds to a different sample. They are mature livers (M1, M2, and M3) and immature livers (IM1, IM2, and IM3) from outer to inner, respectively. b. Distribution of different types of lncRNAs. The antisense, intron, intronic, sense, and intergenic lncRNAs are represented by different concentric rings from inner to outer, according to the loci of lncRNAs in the genome. c. Length distribution of lncRNAs and mRNAs. d Exon number distribution of protein coding transcripts and lncRNAs. e and f. ORFs length distribution of coding transcripts and lncRNAs, and the average value were shown in these two figures
Fig. 2The differential expression of chicken mRNAs and lncRNAs between immature livers and mature livers are shown. a differential expression of mRNAs. the left blue points represent significantly decreased mRNAs in immature livers, gray points represent mRNAs without significantly changes, the right red points represent significantly increased mRNAs in immature livers. b differential expression of lnRNAs. the left blue points represent significantly decreased lncRNAs in immature livers, gray points represent lncRNAs without significantly changes, the right red points represent significantly increased lncRNAs in immature livers
Fig. 3Five differentially expressed mRNAs and five differentially expressed lncRNAs, which were validated by reverse-transcription quantitative polymerase chain reaction. 1. IM represent the immature livers from one-day-old chickens, M represent the mature livers from adult chickens; 2. β-actin was used as an internal control gene for normalization in our experiments. The data were presented as means ± SE (for young chicks: n = 20; for adult chickens: n = 5). Upper letters (a, b) on bars denote significantly different expression levels in the same mRNAs or lncRNAs (P < 0.05)
The significantly enriched KEGG pathways (with P < 0.05) based on the differentially expressed mRNAs
| Pathway Id | pathway description | S gene number | TS gene number | B gene number | TB gene number | P value |
|---|---|---|---|---|---|---|
| ko00190 | Oxidative phosphorylation | 34 | 579 | 88 | 3735 | 0.00 |
| ko00280 | Valine, leucine and isoleucine degradation | 19 | 579 | 42 | 3735 | 0.00 |
| ko01200 | Carbon metabolism | 30 | 579 | 88 | 3735 | 0.00 |
| ko03030 | DNA replication | 13 | 579 | 27 | 3735 | 0.00 |
| ko00640 | Propanoate metabolism | 13 | 579 | 28 | 3735 | 0.00 |
| ko03320 | PPAR signaling pathway | 19 | 579 | 51 | 3735 | 0.00 |
| ko00630 | Glyoxylate and dicarboxylate metabolism | 12 | 579 | 26 | 3735 | 0.00 |
| ko01230 | Biosynthesis of amino acids | 19 | 579 | 53 | 3735 | 0.00 |
| ko00620 | Pyruvate metabolism | 13 | 579 | 31 | 3735 | 0.00 |
| ko00071 | Fatty acid degradation | 12 | 579 | 29 | 3735 | 0.00 |
| ko04216 | Ferroptosis | 12 | 579 | 30 | 3735 | 0.00 |
| ko00260 | Glycine, serine and threonine metabolism | 12 | 579 | 33 | 3735 | 0.00 |
| ko00020 | Citrate cycle (TCA cycle) | 10 | 579 | 25 | 3735 | 0.00 |
| ko01212 | Fatty acid metabolism | 13 | 579 | 39 | 3735 | 0.00 |
| ko00650 | Butanoate metabolism | 9 | 579 | 23 | 3735 | 0.01 |
| ko00380 | Tryptophan metabolism | 11 | 579 | 34 | 3735 | 0.01 |
| ko00072 | Synthesis and degradation of ketone bodies | 5 | 579 | 10 | 3735 | 0.01 |
| ko00310 | Lysine degradation | 12 | 579 | 39 | 3735 | 0.01 |
| ko04110 | Cell cycle | 24 | 579 | 99 | 3735 | 0.01 |
| ko00240 | Pyrimidine metabolism | 20 | 579 | 79 | 3735 | 0.02 |
| ko04146 | Peroxisome | 17 | 579 | 65 | 3735 | 0.02 |
| ko03430 | Mismatch repair | 7 | 579 | 19 | 3735 | 0.02 |
| ko04914 | Progesterone-mediated oocyte maturation | 17 | 579 | 67 | 3735 | 0.02 |
| ko04145 | Phagosome | 25 | 579 | 109 | 3735 | 0.02 |
| ko00220 | Arginine biosynthesis | 6 | 579 | 16 | 3735 | 0.03 |
| ko01210 | 2-Oxocarboxylic acid metabolism | 5 | 579 | 12 | 3735 | 0.03 |
| ko00480 | Glutathione metabolism | 10 | 579 | 34 | 3735 | 0.03 |
| ko00330 | Arginine and proline metabolism | 10 | 579 | 34 | 3735 | 0.03 |
| ko04217 | Necroptosis | 22 | 579 | 95 | 3735 | 0.03 |
| ko03440 | Homologous recombination | 10 | 579 | 36 | 3735 | 0.04 |
| ko00983 | Drug metabolism - other enzymes | 7 | 579 | 22 | 3735 | 0.04 |
| ko00980 | Metabolism of xenobiotics by cytochrome P450 | 8 | 579 | 27 | 3735 | 0.05 |
| ko00900 | Terpenoid backbone biosynthesis | 6 | 579 | 18 | 3735 | 0.05 |
| ko00010 | Glycolysis / Gluconeogenesis | 11 | 579 | 42 | 3735 | 0.05 |
S gene number: the number of significant differentially expressed mRNAs which match to a KEGG term; TS gene number: the number of significant differentially expressed mRNAs which have KEGG annotations; B gene number: the number of detected mRNAs which match to a KEGG term; TB gene number: the number of all detected mRNAs which have KEGG annotations
The KEGG pathway analysis (with P < 0.05) based on the cis- and trans-regulated differentially expressed targets of differentially expressed lncRNAs
| Pathway Id | pathway description | S gene number | TS gene number | B gene number | TB gene number | |
|---|---|---|---|---|---|---|
| ko00190 | Oxidative phosphorylation | 74 | 531 | 76 | 689 | 0.000 |
| ko04514 | Cell adhesion molecules (CAMs) | 34 | 531 | 35 | 689 | 0.001 |
| ko00280 | Valine, leucine and isoleucine degradation | 32 | 531 | 33 | 689 | 0.002 |
| ko00240 | Pyrimidine metabolism | 38 | 531 | 40 | 689 | 0.002 |
| ko00620 | Pyruvate metabolism | 30 | 531 | 31 | 689 | 0.003 |
| ko04260 | Cardiac muscle contraction | 22 | 531 | 22 | 689 | 0.003 |
| ko05168 | Herpes simplex infection | 42 | 531 | 45 | 689 | 0.003 |
| ko04210 | Apoptosis | 40 | 531 | 43 | 689 | 0.005 |
| ko00270 | Cysteine and methionine metabolism | 20 | 531 | 20 | 689 | 0.005 |
| ko00020 | Citrate cycle (TCA cycle | 20 | 531 | 20 | 689 | 0.005 |
| ko01200 | Carbon metabolism | 60 | 531 | 67 | 689 | 0.005 |
| ko01230 | Biosynthesis of amino acids | 38 | 531 | 41 | 689 | 0.007 |
| ko04672 | Intestinal immune network for IgA production | 18 | 531 | 18 | 689 | 0.009 |
| ko03010 | Ribosome | 56 | 531 | 63 | 689 | 0.011 |
| ko00640 | Propanoate metabolism | 24 | 531 | 25 | 689 | 0.011 |
| ko00230 | Purine metabolism | 45 | 531 | 50 | 689 | 0.014 |
| ko00970 | Aminoacyl-tRNA biosynthesis | 16 | 531 | 16 | 689 | 0.015 |
| ko03320 | PPAR signaling pathway | 34 | 531 | 37 | 689 | 0.016 |
| ko04217 | Necroptosis | 28 | 531 | 30 | 689 | 0.018 |
| ko01212 | Fatty acid metabolism | 22 | 531 | 23 | 689 | 0.018 |
| ko00630 | Glyoxylate and dicarboxylate metabolism | 22 | 531 | 23 | 689 | 0.018 |
| ko05164 | Influenza A | 38 | 531 | 42 | 689 | 0.020 |
| ko00480 | Glutathione metabolism | 20 | 531 | 21 | 689 | 0.029 |
| ko04216 | Ferroptosis | 12 | 531 | 12 | 689 | 0.043 |
| ko00983 | Drug metabolism - other enzymes | 12 | 531 | 12 | 689 | 0.043 |
S gene number: the number of significant differentially expressed lncRNAs whose cis-or trans- regulated targets match to a KEGG term; TS gene number: the number of significant differentially expressed lncRNAs whose cis- or trans- regulated targets have KEGG annotations; B gene number: the number of detected lncRNAs whose cis- or trans- regulated targets match to a KEGG term; TB gene number: the number of all detected lncRNAs whose cis- or trans- regulated targets have KEGG annotations
LncRNAs and its potential target genes that are involved in postnatal liver development
| Key protein coding gene | lncRNAs in cis- or trans-roles |
|---|---|
| SNX | MSTRG.5900.3/MSTRG.12856.1/MSTRG.12870.1/MSTRG.13153.1/MSTRG.13191.1/MSTRG.13327.1/MSTRG.13411.1/MSTRG.13471.1/MSTRG.13567.1/MSTRG.13579.1/MSTRG.13597.1/MSTRG.13748.1/MSTRG.13863.1/MSTRG.14503.1/MSTRG.14734.1/MSTRG.15377.1/MSTRG.15517.1/MSTRG.16154.4/MSTRG.16668.1 |
| CYP7A1 | MSTRG.636.1/MSTRG.1039.1/MSTRG.1041.1/MSTRG.1226.1/MSTRG.1392.1/MSTRG.1438.2/MSTRG.7038.1/MSTRG.8045.2/MSTRG.11864.1/MSTRG.12193.1/MSTRG.12936.1/MSTRG.13046.1/MSTRG.13286.1/MSTRG.13438.1/MSTRG.13472.1/MSTRG.13797.1/MSTRG.14192.1/MSTRG.14360.1/MSTRG.14681.1/MSTRG.14723.1/MSTRG.15490.1/MSTRG.15512.1/MSTRG.15585.1/MSTRG.15717.1/MSTRG.15774.1/MSTRG.15789.1/MSTRG.15824.1/MSTRG.16055.1/MSTRG.16119.1/MSTRG.16447.2/MSTRG.16938.1 |
| CYP39A1 | MSTRG.1064.1/MSTRG.3562.1/MSTRG.5948.1/MSTRG.12710.1/MSTRG.12721.1/MSTRG.12856.1/MSTRG.12870.1/MSTRG.13006.1/MSTRG.13157.1/MSTRG.13191.1/MSTRG.13267.1/MSTRG.13298.1/MSTRG.13319.1/MSTRG.13353.1/MSTRG.13411.1/MSTRG.13426.1/MSTRG.13471.1/MSTRG.13515.1/MSTRG.13518.1/MSTRG.13567.1/MSTRG.13597.1/MSTRG.13603.1/MSTRG.13692.1/MSTRG.13748.1/MSTRG.13853.1/MSTRG.13863.1/MSTRG.14018.1/MSTRG.14126.1/MSTRG.14408.1/MSTRG.14481.1/MSTRG.14666.1/MSTRG.14727.1/MSTRG.14734.1/MSTRG.14805.1/MSTRG.14829.1/MSTRG.14838.1/MSTRG.14895.1/MSTRG.15517.1/MSTRG.15518.1/MSTRG.15756.1/MSTRG.15797.1/MSTRG.16379.1/MSTRG.16495.1/MSTRG.16668.1/MSTRG.16961.1/MSTRG.16958.27/MSTRG.16941.1 |
| HNF4α | MSTRG.1039.1/MSTRG.1226.1/MSTRG.1438.2/MSTRG.2310.1/MSTRG.4207.1/MSTRG.5597.1/MSTRG.7038.1/MSTRG.8045.2/MSTRG.10533.1/MSTRG.11864.1/MSTRG.12193.1/MSTRG.12709.1/MSTRG.12721.1/MSTRG.12870.1/MSTRG.13046.1/MSTRG.13222.1/MSTRG.13267.1/MSTRG.13319.1/MSTRG.13353.1/MSTRG.13438.1/MSTRG.13518.1/MSTRG.13567.1/MSTRG.13603.1/MSTRG.13824.1/MSTRG.13863.1/MSTRG.13877.1/MSTRG.13942.1/MSTRG.13960.1/MSTRG.14360.1/MSTRG.14684.1/MSTRG.14723.1/MSTRG.14733.1/MSTRG.14734.1/MSTRG.14838.1/MSTRG.14869.1/MSTRG.15511.1/MSTRG.15512.1/MSTRG.15517.1/MSTRG.15518.1/MSTRG.15585.1/MSTRG.15789.1/MSTRG.16055.1/MSTRG.16119.1/MSTRG.16273.2/MSTRG.16347.1/MSTRG.16447.2/MSTRG.16461.3/MSTRG.16495.1/MSTRG.16941.1 |
| IGF2BP1 | MSTRG.1039.1/MSTRG.1041.1/MSTRG.1226.1/MSTRG.1392.1/MSTRG.1438.2/MSTRG.2310.1/MSTRG.4207.1/MSTRG.5597.1/MSTRG.8045.2/MSTRG.10533.1/MSTRG.11864.1/MSTRG.12193.1/MSTRG.12709.1/MSTRG.12870.1/MSTRG.13046.1/MSTRG.13222.1/MSTRG.13319.1/MSTRG.13438.1/MSTRG.13567.1/MSTRG.13603.1/MSTRG.13640.1/MSTRG.13824.1/MSTRG.13863.1/MSTRG.13877.1/MSTRG.13942.1/MSTRG.14176.1/MSTRG.14360.1/MSTRG.14723.1/MSTRG.14733.1/MSTRG.14869.1/MSTRG.15104.1/MSTRG.15390.1/MSTRG.15435.1/MSTRG.15511.1/MSTRG.15512.1/MSTRG.15517.1/MSTRG.15518.1/MSTRG.15585.1/MSTRG.15717.1/MSTRG.15789.1/MSTRG.15833.1/MSTRG.16055.1/MSTRG.16119.1/MSTRG.16273.2/MSTRG.16347.1/MSTRG.16461.3/MSTRG.16495.1/MSTRG.16941.1 |